Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants

Sophie Testa(Istituti Ospitalieri di Cremona), Gualtiero Palareti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)

Journal of Thrombosis and Haemostasis

April 23, 2019

10.1111/jth.14457

Cited by 130

Related Papers

Oral Anticoagulant Therapy

|CHEST Journal|2012|1.5k

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

|BMJ|2019|312

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis

|Journal of Thrombosis and Haemostasis|2010|209

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

|Journal of Thrombosis and Haemostasis|2005|202

Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C Resistance

|Arteriosclerosis Thrombosis and Vascular Biology|1999|161